Atlas Trials

Evaluation of Novel Iron-based Lymphatic Mapping Agent, Magtrace, for Delayed Sentinel Lymph Node Biopsy (SLNB) in Ductal Carcinoma In-Situ (DCIS)

Clinical trial NCT06868238 · SUSPENDED

Trial details

NCT number
NCT06868238
Sponsor
University of Florida
Status
SUSPENDED
Phase
Phase 2
Study type
INTERVENTIONAL
Ductal Carcinoma in Situ
Start date
2026-08-01
Primary completion
2029-06-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.